The workup for late-onset MADD should be considered in patients with steatohepatitis unrelated to obesity and associated with elevated aspartate aminotransferase, alanine aminotransferase, nonketotic hypoglycemia, acidosis, and muscle involvement. This evidence concerns the gene GPT and obesity disorder.